Home
Fox Rothschild LLP
David Restaino
David Restaino
Fox Rothschild LLP
OIG Adopts Fiscal Year 2015 Work Plan
03 Nov 2014 | United States
FDA Issues Draft Guidance On Tracing Prescription Drug Products, Drug Distribution And Third-Party Logistics
03 Nov 2014 | United States
OIG Proposes New "Safe Harbor" Rule
28 Oct 2014 | United States
FDA Releases Guidance On Cybersecurity In Medical Devices
03 Oct 2014 | United States
OIG Releases Advisory Opinion Concerning Preferred Hospital Networks
02 Oct 2014 | United States
OIG Issues Special Advisory Bulletin Regarding Manufacturing Copayment Coupons
25 Sep 2014 | United States
Let’s Not Forget About State Enforcement
08 Sep 2014 | United States
OIG Posts Study Of Nursing Facilities’ Compliance In Reporting Allegations Of Abuse Or Neglect
29 Aug 2014 | United States
OIG Focuses On Medicaid Billing For Pediatric Dental Services
29 Aug 2014 | United States
Generic Drug Developments: FDA ‘Controlled Correspondence’ Guidance Is Proposed
28 Aug 2014 | United States
OIG Focuses On Medicaid Billing For Pediatric Dental Services
21 Aug 2014 | United States
OIG Posts Study Of Nursing Facilities’ Compliance In Reporting Allegations Of Abuse Or Neglect
19 Aug 2014 | United States
OIG Posts Advisory Opinion On Pharmacy Referrals
18 Aug 2014 | United States
OIG Enforcement Update
15 Aug 2014 | United States
FDA Posts Draft Guidance On Class I And Class II Medical Devices
14 Aug 2014 | United States
Transactions - July 2014
05 Aug 2014 | United States
OIG Provides Testimony On Health Insurance Marketplaces
25 Jul 2014 | United States
FDA Issues Guidance Concerning Institutional Review Boards
30 Jun 2014 | United States
FDA Releases Guidance On Global Unique Device Identification Database (GUDID)
30 Jun 2014 | United States
FDA Releases Draft Guidance For Industry Concerning Social Media
24 Jun 2014 | United States
< 1 2 3 >
Contact Details
Philadelphia
Philadelphia
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.